The Trump plan to reduce drug prices — are American patients first?

Cancer drug prices continue to increase by 10 to 12 percent every year. Spending on cancer drugs doubled in the past five years, and will double again by 2022. All cancer drugs approved by the Food and Drug Administration in 2017 were priced above $160,000 per year.

Patients are additionally burdened with crushing out-of-pocket prescription expenses.

Head In Ass Train Comments on July 2, 2018 in No Category.
Add Comment
0 Comments

Your Comment

By posting your comment, you agree to the privacy policy and terms of service.